European Management of Glanzmann’s Thrombasthenia from EAHAD’s Working Group
European Association for Haemophilia and Allied Disorders (EAHAD) shared on LinkedIn:
”Care for Glanzmann’s thrombasthenia still varies widely across Europe, from antibody screening practices to access to HLA-matched platelets.
A new publication from the EAHAD Glanzmann Thrombasthenia Working Group highlights areas of agreement and where further alignment is needed.
Read more on the Haemophilia Journal.”
Read the full article in Haemophilia Journal.
Article: European Management of Glanzmann’s Thrombasthenia: A Survey of Current Clinical Practice
Authors: Mathieu Fiore, Andrea Artoni, Robert Klamroth, Mary Mathias, Roger Schutgens, Roseline d’Oiron, EAHAD Glanzmann Thrombasthenia Working Group
Stay updated on all scientific advances in the field of platelet disorders with Hemostasis Today.
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:23Joseph R. Shaw: Thrombin Generation and the Pharmacodynamics of Oral Anticoagulants